• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Google Charity Fuses $1M to AI-Driven Dementia App

Share:

September 19, 2023

Google.org has granted A$2 million ($1.3 million) to the Music Attuned Technology – Care via eHealth (MATCH) project, led by researchers from the University of Melbourne. The project is developing a wearable sensor and AI-enabled music adaptive system to regulate the mood of dementia patients, thereby reducing challenging behaviours. The AI system will learn each user’s unique agitation behaviours and positive music interventions using wearable sensors and provide targeted music to soothe and calm them. The grant will also fund a pilot of the MATCH app in Australia ahead of a global rollout.

A research project led by researchers from the University of Melbourne will be receiving A$2 million ($1.3 million) in funding and support from Google.org.

The MATCH (Music Attuned Technology – Care via eHealth) project is one of the 15 projects selected for the $25 million AI for the Global Goals grant, which seeks to help organisations accelerate progress towards meeting the United Nation’s Sustainable Development Goals.

MATCH provides music-based interventions to regulate the mood of users with dementia, thereby preventing the development of or the severity of challenging behaviours.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

WHAT IT’S FOR

The Google.org grant will support the project’s development of wearable sensors and AI-enabled music adaptive systems.

The first component of the MATCH project – a prototype of a training package app for caregivers with a curated list of music that enables targeted intervention – has already been developed. With the grant, a music-adaptive system will be developed and integrated with this existing prototype app.

According to a media release, the AI system will learn each user’s unique agitation behaviours and positive music interventions using wearable sensors, along with observation, analysis, and music treatment. The user’s preferred music will then adapt to synchronise and treat their agitation.

“We will be able to develop a device, similar to a smartwatch, that can monitor movement, heart rate and other biomarkers. Should it detect signs of agitation, the app will play music from a curated playlist designed to soothe and calm them. If the initial music choice isn’t effective, it will continue to change tracks until the person’s state stabilises,” University of Melbourne professor Lars Kulik, who leads the AI development and integration of sensor data in the MATCH project, further explained.

Moreover, the fresh grant will also fund the MATCH app’s pilot in Australia in preparation for a global rollout in the future.

MATCH was also recently awarded an A$156,000 ($100,000) grant from Aged Care Research and Industry Innovation Australia to support its new study. Called MATCH-H, the study will focus on implementing the MATCH Music Training Program in a specialist advanced dementia inpatient hospital unit.

WHY IT MATTERS

According to the University of Melbourne, about nine in 10 of all people living with dementia in the world today display agitation, which is recognised as a challenging symptom that can lead to physical and verbal aggression, distress to families and professional carers, and ultimately, poorer quality of life.

Access to music and art therapy, which helps relieve agitation among people with dementia, has been recommended by the Australian government’s Royal Commission into Aged Care Quality and Safety to be provided by every aged care centre in Australia by July 2024. However, the present shortage of music therapists poses a challenge in meeting this recommendation.

The MATCH project is overcoming this hurdle by combining music with wearable sensors and AI to create a music-adaptive system for the early detection and treatment of agitations.

Researchers claim that their music attunement intervention has the potential to lessen agitation as well as reduce the costs of care per person with dementia. Carers can also do away from pharmacological interventions, which can increase confusion and other side effects for patients.

The research team is now seeking residential aged care homes and people living with dementia at home to participate in the testing of their prototype app and upcoming music-adaptive system.

MARKET SNAPSHOT

Recent innovations in neurotechnology also use AI to measure the progression of Alzheimer’s disease, the most common form of dementia. Early this year, CSIRO researchers, together with the Queensland University of Technology, introduced what could be the world’s first AI-based benchmark for measuring brain atrophy, which appears years ahead of the onset of Alzheimer’s symptoms.

Outside Australia, Fujifilm has also developed an AI tool that can predict whether patients with mild cognitive impairment will advance to Alzheimer’s disease within two years.

ON THE RECORD

“Many carers of people with dementia recognise music’s value in supporting the wellbeing of a loved one. We are working to create a better everyday life for people living with dementia, their families, and carers on the dementia journey using the proven therapeutic benefits of music, alongside wearable sensors and AI,” said Felicity Baker, University of Melbourne professor and principal investigator of the MATCH project.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Johnson & Johnson to Buy Surgical Robotics Firm Auris for $3.4 BillionJohnson & Johnson to Buy Surgical Robotics Firm Auris for $3.4 Billion
  • ’Data Minimalization’ Could be Key to Helping Doctors Through Data Overload’Data Minimalization’ Could be Key to Helping Doctors Through Data Overload
  • Sensyne Health to Assist UK MHRA in Developing Verification Methods for Digital Health AlgorithmsSensyne Health to Assist UK MHRA in Developing Verification Methods for Digital Health Algorithms
  • Formation and Safanad Sell RHA Health Services to Blue WolfFormation and Safanad Sell RHA Health Services to Blue Wolf
  • Almirall acquires Allergan U.S. medical dermatology portfolio*Almirall acquires Allergan U.S. medical dermatology portfolio*
  • Probo Medical Acquires IMAX MedicalProbo Medical Acquires IMAX Medical
  • How Big Pharma is Using AI for Drug Discovery, Clinical Trials, and MoreHow Big Pharma is Using AI for Drug Discovery, Clinical Trials, and More
  • Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency DisorderMarinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications